What is the appropriate dose of Augmentin (amoxicillin 600 mg/clavulanate 5 mg) for a 45‑lb (≈20 kg) child with acute otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin ES-600 Dosing for 45 lb Child with Acute Otitis Media

For a 45 lb (approximately 20 kg) child with acute otitis media, administer Augmentin ES-600 (600 mg amoxicillin/42.9 mg clavulanate per 5 mL) at 10 mL twice daily for 10 days, providing 90 mg/kg/day of amoxicillin.

Dosing Calculation

  • Child's weight: 45 lb = 20.4 kg 1
  • Recommended dose: 90 mg/kg/day of amoxicillin component divided into 2 doses 1, 2
  • Total daily amoxicillin: 20.4 kg × 90 mg/kg = 1,836 mg/day
  • Per dose: 918 mg amoxicillin twice daily
  • Volume per dose: Approximately 10 mL of ES-600 suspension twice daily 2

This provides the high-dose amoxicillin-clavulanate regimen (90/6.4 mg/kg/day) in a 14:1 ratio that is specifically designed for acute otitis media 1, 2.

Clinical Rationale

High-dose amoxicillin-clavulanate is the preferred first-line treatment for children with acute otitis media who:

  • Have received amoxicillin in the previous 30 days 1
  • Are younger than 2 years with bilateral AOM 1
  • Have concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome) 1
  • Require coverage for β-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis 1

The ES-600 formulation achieves 96-98% bacteriologic eradication rates against Streptococcus pneumoniae (including penicillin-resistant strains with MICs of 2-4 mcg/mL) and 92-94% eradication of H. influenzae 2, 3.

Treatment Duration and Monitoring

  • Duration: 10 days of therapy 1, 2
  • Clinical assessment: Evaluate treatment response at 48-72 hours 1
  • Treatment failure criteria: Lack of improvement or worsening after 48-72 hours warrants consideration of alternative therapy (ceftriaxone 50 mg/kg IM/IV daily for 3 days) 1

Safety Profile

The ES-600 formulation has a favorable safety profile with protocol-defined diarrhea occurring in approximately 11-13% of children, which is comparable to standard-dose formulations 2. The 14:1 ratio of amoxicillin to clavulanate minimizes gastrointestinal side effects while maintaining β-lactamase inhibition 2, 4.

Common adverse effects include:

  • Diarrhea (11-13%) 2
  • Diaper rash/contact dermatitis (6%) 2
  • Vomiting (6-7%) 2

Alternative Considerations

If the child has taken amoxicillin within the past 30 days or has moderate-to-severe illness, high-dose amoxicillin-clavulanate is specifically indicated over standard-dose amoxicillin 1, 5. For children with true penicillin allergy (not just intolerance), alternative agents include cefdinir (14 mg/kg/day) or ceftriaxone 1.

The WHO guidelines recommend amoxicillin 40 mg/kg twice daily for uncomplicated acute otitis media in resource-limited settings 6, but current U.S. guidelines favor the higher 80-90 mg/kg/day dosing to address increasing antimicrobial resistance 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.